[HTML][HTML] Mechanistic understanding of Candida albicans biofilm formation and approaches for its inhibition

T Atriwal, K Azeem, FM Husain, A Hussain… - Frontiers in …, 2021 - frontiersin.org
In recent years, the demand for novel antifungal therapies has increased several-folds due
to its potential to treat severe biofilm-associated infections. Biofilms are made by the sessile …

Targeting Candida albicans filamentation for antifungal drug development

T Vila, JA Romo, CG Pierce, SF McHardy, SP Saville… - Virulence, 2017 - Taylor & Francis
Candida albicans remains the main etiological agent of candidiasis, as this otherwise
normal commensal of humans is capable of causing active infection in immune-and …

[HTML][HTML] Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study

HH Lara, DG Romero-Urbina, C Pierce… - Journal of …, 2015 - Springer
Background Candida albicans is the most common pathogenic fungus isolated in
bloodstream infections in hospitalized patients, and candidiasis represents the fourth most …

Fungal quorum sensing molecules: role in fungal morphogenesis and pathogenicity

T Wongsuk, P Pumeesat… - Journal of basic …, 2016 - Wiley Online Library
When microorganisms live together in high numbers, they need to communicate with each
other. To achieve cell–cell communication, microorganisms secrete molecules called …

In Vitro Culturing and Screening of Candida albicans Biofilms

M Gulati, MB Lohse, CL Ennis… - Current protocols in …, 2018 - Wiley Online Library
Candida albicans is a normal member of the human microbiota that asymptomatically
colonizes healthy individuals, however it is also an opportunistic pathogen that can cause …

Tackling fungal resistance by biofilm inhibitors

S Wu, Y Wang, N Liu, G Dong… - Journal of Medicinal …, 2017 - ACS Publications
The high incidence and mortality of invasive fungal infections and serious drug resistance
have become a global public health issue. The ability of fungal cells to form biofilms is an …

Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis

MS Ahmad Khan, F Alshehrei, SB Al-Ghamdi… - Future science …, 2020 - Future Science
Candida albicans has remained the main etiological agent of candidiasis, challenges
clinicians with high mortality and morbidity. The emergence of resistance to antifungal drugs …

Assessment and Optimizations of Candida albicansIn Vitro Biofilm Assays

MB Lohse, M Gulati, A Valle Arevalo… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Candida albicans biofilms have a significant medical impact due to their rapid growth on
implanted medical devices, their resistance to antifungal drugs, and their ability to seed …

[HTML][HTML] Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis

Y Sutar, S Nabeela, S Singh, A Alqarihi, N Solis… - PLoS …, 2022 - journals.plos.org
Candida albicans biofilms are a complex multilayer community of cells that are resistant to
almost all classes of antifungal drugs. The bottommost layers of biofilms experience nutrient …

[HTML][HTML] Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans …

F Guilhelmelli, N Vilela, KS Smidt… - Frontiers in …, 2016 - frontiersin.org
The incidence of fungal infections has been increasing in the last decades, while the
number of available antifungal classes remains the same. The natural and acquired …